These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31442625)

  • 1. Phylogenomic and epidemiological insights into two clinical Mycobacterium bovis BCG strains circulating in South Africa.
    Modipane L; Reva O; Magazi BT; Antiabong JF; Osei Sekyere J; Mbelle NM
    Int J Infect Dis; 2019 Oct; 87():32-38. PubMed ID: 31442625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.
    Mahairas GG; Sabo PJ; Hickey MJ; Singh DC; Stover CK
    J Bacteriol; 1996 Mar; 178(5):1274-82. PubMed ID: 8631702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive survey of single nucleotide polymorphisms (SNPs) across Mycobacterium bovis strains and M. bovis BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis strains and M. bovis BCG strains.
    Garcia Pelayo MC; Uplekar S; Keniry A; Mendoza Lopez P; Garnier T; Nunez Garcia J; Boschiroli L; Zhou X; Parkhill J; Smith N; Hewinson RG; Cole ST; Gordon SV
    Infect Immun; 2009 May; 77(5):2230-8. PubMed ID: 19289514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy.
    Liu J; Tran V; Leung AS; Alexander DC; Zhu B
    Hum Vaccin; 2009 Feb; 5(2):70-8. PubMed ID: 19164935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Multiplex Real-Time PCR Assay for Mycobacterium bovis BCG and Validation in a Clinical Laboratory.
    Duffy SC; Venkatesan M; Chothe S; Poojary I; Verghese VP; Kapur V; Behr MA; Michael JS
    Microbiol Spectr; 2021 Oct; 9(2):e0109821. PubMed ID: 34494864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First insight into the whole-genome sequence variations in Mycobacterium bovis BCG-1 (Russia) vaccine seed lots and their progeny clinical isolates from children with BCG-induced adverse events.
    Narvskaya O; Starkova D; Levi D; Alexandrova N; Molchanov V; Chernyaeva E; Vyazovaya A; Mushkin A; Zhuravlev V; Solovieva N; Vishnevskiy B; Mokrousov I
    BMC Genomics; 2020 Aug; 21(1):567. PubMed ID: 32811436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rifampicin-resistant Mycobacterium bovis BCG strain isolated from an infant with NEMO mutation].
    Çavuşoğlu C; Edeer Karaca N; Azarsız E; Ulusoy E; Kütükçüler N
    Mikrobiyol Bul; 2015 Apr; 49(2):272-7. PubMed ID: 26167828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomics of BCG vaccines by whole-genome DNA microarray.
    Behr MA; Wilson MA; Gill WP; Salamon H; Schoolnik GK; Rane S; Small PM
    Science; 1999 May; 284(5419):1520-3. PubMed ID: 10348738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant.
    Keller PM; Böttger EC; Sander P
    BMC Microbiol; 2008 Jul; 8():120. PubMed ID: 18637199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue specific diversification, virulence and immune response to
    Korol CB; Shallom SJ; Arora K; Boshoff HI; Freeman AF; King A; Agrawal S; Daugherty SC; Jancel T; Kabat J; Ganesan S; Torrero MN; Sampaio EP; Barry C; Holland SM; Tettelin H; Rosenzweig SD; Zelazny AM
    Virulence; 2020 Dec; 11(1):1656-1673. PubMed ID: 33356838
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.
    Al-Hajoj S; Memish Z; Abuljadayel N; AlHakeem R; AlRabiah F; Varghese B
    PLoS One; 2014; 9(11):e113472. PubMed ID: 25409184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference genome and comparative genome analysis for the WHO reference strain for Mycobacterium bovis BCG Danish, the present tuberculosis vaccine.
    Borgers K; Ou JY; Zheng PX; Tiels P; Van Hecke A; Plets E; Michielsen G; Festjens N; Callewaert N; Lin YC
    BMC Genomics; 2019 Jul; 20(1):561. PubMed ID: 31286858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
    Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic characteristics of two most widely used BCG vaccine strains: Danish 1331 and Pasteur 1173P2.
    Asadian M; Hassanzadeh SM; Safarchi A; Douraghi M
    BMC Genomics; 2022 Aug; 23(1):609. PubMed ID: 35987561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mosaic structure of Mycobacterium bovis BCG genomes as a representation of phage sequences' mobility.
    Voronina OL; Kunda MS; Aksenova EI; Semenov AN; Ryzhova NN; Lunin VG; Gintsburg AL
    BMC Genomics; 2016 Dec; 17(Suppl 14):1009. PubMed ID: 28105923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of Mycobacterium bovis bacillus Calmette-Guérin (BCG) Danish in white-tailed deer (Odocoileus virginianus) vaccinated with a lipid-formulated oral vaccine.
    Palmer MV; Thacker TC; Waters WR; Robbe-Austerman S; Aldwell FE
    Transbound Emerg Dis; 2014 Jun; 61(3):266-72. PubMed ID: 23173832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].
    Prygiel M; Janaszek-Seydlitz W; Bucholc B
    Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR-based genomic deletion analysis of RD-regions in the identification of mycobacteria isolated from adverse events following BCG vaccination or TB suspected cases.
    Krysztopa-Grzybowska K; Brzezińska S; Augustynowicz-Kopeć E; Augustynowicz E; Lutyńska A
    Pol J Microbiol; 2014; 63(3):359-62. PubMed ID: 25546948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.